SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-039504
Filing Date
2017-02-13
Accepted
2017-02-13 09:21:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d349884dsc13ga.htm SC 13G/A 33869
  Complete submission text file 0001193125-17-039504.txt   35084
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Subject) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88403 | Film No.: 17596263
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5375 MEDPACE WAY CINCINNATI OH 45227
Business Address
Troendle August J. (Filed by) CIK: 0001622058 (see all company filings)

Type: SC 13G/A